QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL…

Presence of Particulate Matter

Date

2025-11-05

Country

United States

Brand

QuVa Pharma

Product

R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL…

Classification

Class II

Units

U.S. Nationwide

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More QuVa Pharma recalls

1. 2026-07-15
2. US
   Drugs & medicalClass II

   QuVa Pharma, Inc. recalls Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100,…

   Failed Impurities/Degradation Specifications

   FDA · DrugQuVa Pharma, Inc.Nationwide within the United StatesOfficial notice →
3. 2025-04-02
4. US
   Drugs & medicalClass II

   QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection…

   Lack of Assurance of Sterility

   FDA · DrugQuVa Pharma, Inc.U.S. NationwideOfficial notice →
5. 2022-10-05
6. US
   Drugs & medicalClass III

   QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for…

   Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

   FDA · DrugQuVa Pharma, Inc.Nationwide in the USAOfficial notice →

Other drugs & medical recalls in the United States

1. 2025-11-05
2. US
   Drugs & medicalClass II

   ACME UNITED CORPORATION recalls Sting Relief Swabs, First Aid Only, 10 Swabs per box, part number 19-001, Manufactured for: Acme United Corporation, 1 Waterview Dr.…

   Product Mix-up

   FDA · DrugACME UNITED CORPORATIONUSA NationwideOfficial notice →
3. US
   Drugs & medicalClass II

   Kenvue Brands LLC recalls TYLENOL, Acetaminophen, Extra Strength, 24 Caplets, 500mg each, distributed by: Johnson & Johnson Consumer Inc., McNeil Consumer…

   Defective Container

   FDA · DrugKenvue Brands LLCU.S. Nationwide - CO, IL, OH and IN.Official notice →
4. US
   Drugs & medicalClass II

   ProRx LLC recalls Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton,…

   Lack of Assurance of Sterility

   FDA · DrugProRx LLCTX and UTOfficial notice →
5. US
   Drugs & medicalClass II

   Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by: USV Private Limited,…

   CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

   FDA · DrugHeritage Pharmaceuticals IncU.S. Nationwide.Official notice →
6. US
   Drugs & medicalClass II

   Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100…

   CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.

   FDA · DrugTeva Pharmaceuticals USA, IncU.S. NationwideOfficial notice →
7. US
   Drugs & medicalClass II

   Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging,…

   Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit

   FDA · DrugAmerisource Health Services LLCNationwide within the United StatesOfficial notice →